Public equity report: Symbiotic Capital launches with $600M credit fund

There’s a new life sciences debt lender in town, which boasts a $600 million fund and the backing of a biotech pioneer.

Symbiotic Capital, which launched on Tuesday with an inaugural $600 million credit fund, was co-founded by Arie Belldegrun, who serves as its co-chairman, and is affiliated with his investment firm, Bellco Capital. Belldegrun has co-founded numerous biotechs over the past four decades, including Cougar Biotechnology Inc. and Kite Pharma Inc., along with life sciences VC firm Vida Ventures...